A leading Indian multinational pharmaceutical company specializing in generics, APIs, and finished formulations identified over 4,000 duplicate cases through internal quality checks ahead of an upcoming FDA audit. With a three-month deadline and no scope for additional hiring, Vigilare initiated a rapid-response mini-project to merge, cleanse, and validate records.
By mobilizing experienced personnel from ongoing projects within 24 hours and implementing focused onboarding and training, a dedicated team was deployed to execute the assignment. Through structured planning, rigorous quality control, and close stakeholder coordination, the project was completed on schedule with high accuracy.
Client satisfaction led to a contract extension covering an additional 10,000+ cases, which were also delivered successfully within timelines, reinforcing Vigilare’s operational agility and commitment to quality excellence. For more information, download the case study.
Comments are closed